to enhance the health and quality of life of people throughout the world. For more than 80 years, Novo Nordisk has combined drug discovery with technology to turn science into solutions for people with diabetes, people with hemophilia, children with growth hormone deficiency, and women experiencing the symptoms of menopause. Our commitment to diabetes research is reflected in our variety of insulin products, other medical solutions, and the many exciting new treatment options in our pipeline. At Novo Nordisk, dedicated people with expertise in many areas work together to develop pharmaceuticals, advanced delivery systems, and customized services.